Toronto Dominion Bank
RPRX icon

Toronto Dominion Bank’s Royalty Pharma RPRX Stock Holding History

Toronto Dominion Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-43,714
Closed -$1.15M – 1389
2024
Q2 		$1.15M Buy
43,714
+2,172
+5% +$60.2K ﹤0.01% 874
2024
Q1 		$1.26M Sell
41,542
-13,388
-24% -$395K ﹤0.01% 851
2023
Q4 		$1.54M Sell
54,930
-48,061
-47% -$1.32M ﹤0.01% 904
2023
Q3 		$2.8M Buy
+102,991
New +$3.06M ﹤0.01% 806

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank's RPRX Position: Q3 2024 in Review

Toronto Dominion Bank sold out of Royalty Pharma (RPRX) in Q3 2024, closing a stake of 43,714 shares — an estimated $1.15M sold.

Toronto Dominion Bank first reported a position in RPRX in Q3 2023 and held it in 4 quarters. The position peaked at $2.8M in Q3 2023. 395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.

  • Toronto Dominion Bank reported no remaining Royalty Pharma position as of Q3 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 43,714 Royalty Pharma shares in Q3 2024, an estimated $1.15M.
  • Toronto Dominion Bank first reported a position in Royalty Pharma in Q3 2023 and held it in 4 quarters.
  • Toronto Dominion Bank's Royalty Pharma position peaked at $2.8M in Q3 2023.
  • 395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.